• Net Income: $5 million or $0.14 per unit for Q1 2025.
• Consolidated Net Income: $42 million on consolidated net sales of $238 million.
• Distributable Cash Flow: $5 million or $0.13 per unit for Q1 2025.
• Cash Balance and Investments: $154 million at the end of Q1 2025.
• Long-term Debt: $400 million, with $377 million at the Partnership and $23 million at OpCo.
• Capital Expenditures: $16 million spent by OpCo in Q1 2025.
• Quarterly Distribution: $0.4714 per unit announced for Q1 2025.
• Distribution Growth: 71% increase since the IPO's original minimum quarterly distribution.
• Distribution Coverage Ratio: Approximately 1.1 times since IPO.

• Warning! GuruFocus has detected 7 Warning Signs with WLKP.

Release Date: May 02, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

• Westlake Chemical Partners LP (NYSE:WLKP) reported a net income of $5 million or $0.14 per unit for the first quarter of 2025.
• The company has maintained 43 consecutive quarterly distributions since its IPO in July 2014, demonstrating a strong track record of reliable distributions.
• WLKP's Ethylene Sales Agreement provides a predictable fee-based cash flow structure, minimizing market volatility and production risk.
• The partnership has a strong balance sheet with a consolidated cash balance and cash investments totaling $154 million.
• WLKP has a conservative leverage ratio of approximately 1 times, indicating strong financial health.

Negative Points

• First quarter 2025 net income was $10 million below the first quarter 2024 due to lower production and sales volume from the planned turnaround at Petro 1.
• Distributable cash flow decreased by $12 million compared to the first quarter of 2024, impacted by lower production and higher maintenance capital expenditures.
• The planned turnaround at Petro 1 resulted in lower production and sales volume, affecting quarterly earnings.
• Global trade tensions have intensified, creating uncertainty for businesses and investors, which could impact future performance.
• Elevated interest rates are weighing on the company's loan obligations, potentially affecting financial performance.

Q & A Highlights

Q: It seems like the financial impact of the Q1 turnaround at Petro 1 was more significant on your quarterly earnings than previous turnarounds. Could you help us understand that? Was it due to the size of the turnaround or any unplanned expenses? A: Steve Bender, CFO: The impact was as planned. The unit was down for February and March, which was expected. The elevated interest rates affecting loan obligations might be a factor you're considering, but the performance was as budgeted.

Q: The valuation difference between the parent Westlake and the MLP, Westlake LP, seems to have compressed lately. Is there still enough of a valuation difference to justify keeping Westlake LP around? A: Steve Bender, CFO: Despite some compression in valuations, the value proposition remains over the business cycle. The valuation differential between the partnership and Westlake Corporation remains elevated over a reasonable cycle period.

Q: Can you provide more details on the financial results for the first quarter of 2025? A: Steve Bender, CFO: Westlake Partners reported a net income of $5 million or $0.14 per unit. Consolidated net income, including OpCo's earnings, was $42 million on consolidated net sales of $238 million. Distributable cash flow for the quarter was $5 million or $0.13 per unit.

Q: How did the planned turnaround at Petro 1 affect the financial results compared to the previous year? A: Steve Bender, CFO: The first quarter 2025 net income was $10 million below the first quarter 2024 primarily due to lower production and sales volume from the planned turnaround at Petro 1. Distributable cash flow decreased by $12 million compared to the first quarter of 2024.

Q: What is the outlook for future production and any planned turnarounds? A: Jean-Marc Gilson, CEO: The successful completion of the Petro 1 turnaround positions us for solid production levels. There are no further planned turnarounds in 2025 or 2026, and the Ethylene Sales Agreement will continue to provide stable and predictable cash flows.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.